Charles Gore took over as Executive Director of the Medicines Patent Pool (MPP), a Geneva-based foundation, in July 2018, just after its board decided to significantly expand its mandate into “essential medicines” – those therapies most critical to tackling some of the world’s leading diseases. Nine months into his term, Health Policy Watch’s William New talked about the strategic course he is steering.Continue reading ->
Image Credits: MPP.